DNAAF3 Gene Primary Ciliary Dyskinesia Type 2 NGS Genetic DNA Test
Introduction to the Test
The DNAAF3 Gene Primary Ciliary Dyskinesia Type 2 NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to identify genetic mutations associated with Primary Ciliary Dyskinesia (PCD), a disorder that affects the cilia’s ability to function properly. Cilia are tiny hair-like structures that line the respiratory tract and play a vital role in clearing mucus and pathogens. Understanding the genetic basis of PCD is crucial for effective management and treatment.
What the Test Measures
This test specifically examines the DNAAF3 gene, which is implicated in the proper functioning of cilia. By analyzing this gene through Next Generation Sequencing (NGS) technology, the test can detect mutations that may lead to PCD. This is essential for patients presenting with symptoms of chronic respiratory issues.
Who Should Consider This Test
Individuals who experience the following symptoms should consider undergoing the DNAAF3 Gene Primary Ciliary Dyskinesia Type 2 NGS Genetic DNA Test:
- Chronic respiratory infections
- Persistent cough
- Frequent sinusitis or ear infections
- Symptoms of PCD in family history
Risk factors include a family history of PCD or related respiratory disorders. Consulting with an ENT doctor or a genetic specialist can help determine the necessity of this test.
Benefits of Taking the Test
The benefits of the DNAAF3 Gene Primary Ciliary Dyskinesia Type 2 NGS Genetic DNA Test include:
- Accurate diagnosis of PCD, allowing for targeted treatment strategies.
- Understanding the genetic basis of respiratory symptoms, leading to better patient management.
- Empowering patients and families with knowledge about hereditary risks.
- Facilitating genetic counseling and family planning decisions.
Understanding Your Results
Results from the DNAAF3 Gene Primary Ciliary Dyskinesia Type 2 NGS Genetic DNA Test will be interpreted by qualified genetic counselors or specialists. They will guide patients through the implications of their test results, including potential treatment options and management strategies.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| DNAAF3 Gene Primary Ciliary Dyskinesia Type 2 NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Branches and Booking
We have branches across all major cities in Kenya, making it easy for you to access our services. Additionally, we offer home sample collection services for your convenience. To book the DNAAF3 Gene Primary Ciliary Dyskinesia Type 2 NGS Genetic DNA Test, please call or WhatsApp us at +254711564616. Take control of your health today!
